Company Filing History:
2 out of 855 
1 out of 1 
1 out of 832,891 Years Active: 2004-2009
Title: Hiroshi Konno: Innovator in Antitumor and Anti-inflammatory Research
Introduction
Hiroshi Konno is a notable inventor based in Akita, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with antitumor and anti-inflammatory properties. With a total of 3 patents to his name, Konno's work is recognized for its potential impact on cancer treatment and related therapies.
Latest Patents
One of Konno's latest patents is focused on a substance that exhibits antitumor and anti-inflammatory activity. This compound, represented by a specific formula, demonstrates excellent antitumor activity and angiogenesis inhibitory action under low oxygen conditions. It serves as an active ingredient in medicaments such as antitumor agents and anti-inflammatory agents. Another significant patent is for the PKB-3564 substance, which has neovascularization inhibitory activity. This compound is characterized by a complex formula and is useful as an active ingredient in medicaments that possess angiogenesis suppressive activity, apoptosis suppressive activity, and cell cycle inhibitory activity.
Career Highlights
Throughout his career, Hiroshi Konno has worked with Riken Corporation, where he has contributed to various research projects. His innovative work has positioned him as a key figure in the field of medicinal chemistry, particularly in the development of therapeutic agents.
Collaborations
Konno has collaborated with notable colleagues such as Hiroyuki Osada and Hideaki Kakeya. These collaborations have further enhanced his research and development efforts in the field.
Conclusion
Hiroshi Konno's contributions to medicinal chemistry, particularly in the area of antitumor and anti-inflammatory compounds, highlight his role as an influential inventor. His patents reflect a commitment to advancing medical science and improving treatment options for patients.